Free Trial

Ci Capital Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Ci Capital. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Ci Capital.

Average Return
00.00% 12-Month ROI
Total Ratings
1 Last 12 Months
Buy Ratings
0 Last 12 Months
Sell Ratings
0 Last 12 Months
Companies Covered
1 Last 12 Months
MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetails
InflaRx N.V. stock logo
IFRX
InflaRx
$1.65
+5.1%
9/14/2020 Reiterated Rating$7.00HoldView details for Ci Capital rating of InflaRx (NASDAQ:IFRX) on 9/14/2020
Calliditas Therapeutics AB (publ) stock logo
CALT
Calliditas Therapeutics AB (publ)
$40.00
8/18/2020 Reiterated Rating$44.00BuyView details for Ci Capital rating of Calliditas Therapeutics AB (publ) (NASDAQ:CALT) on 8/18/2020
Avadel Pharmaceuticals PLC. stock logo
AVDL
Avadel Pharmaceuticals
$15.76
+5.1%
8/11/2020 Reiterated Rating$22.00BuyView details for Ci Capital rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 8/11/2020
Crescent Biopharma, Inc. stock logo
CBIO
Crescent Biopharma
$14.24
+4.0%
8/6/2020 Reiterated Rating$1,800.00BuyView details for Ci Capital rating of Crescent Biopharma (NASDAQ:CBIO) on 8/6/2020
Immunovant, Inc. stock logo
IMVT
Immunovant
$17.14
+6.3%
8/5/2020 Reiterated Rating$32.00BuyView details for Ci Capital rating of Immunovant (NASDAQ:IMVT) on 8/5/2020
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
$3.28
+1.5%
8/5/2020 Reiterated Rating$35.00BuyView details for Ci Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 8/5/2020
Crescent Biopharma, Inc. stock logo
CBIO
Crescent Biopharma
$14.24
+4.0%
7/22/2020 Reiterated Rating$1,900.00BuyView details for Ci Capital rating of Crescent Biopharma (NASDAQ:CBIO) on 7/22/2020
MEI Pharma, Inc. stock logo
MEIP
MEI Pharma
$4.23
-0.9%
7/5/2020 Reiterated Rating$180.00BuyView details for Ci Capital rating of MEI Pharma (NASDAQ:MEIP) on 7/5/2020
MEI Pharma, Inc. stock logo
MEIP
MEI Pharma
$4.23
-0.9%
6/22/2020 Reiterated Rating$180.00BuyView details for Ci Capital rating of MEI Pharma (NASDAQ:MEIP) on 6/22/2020
InflaRx N.V. stock logo
IFRX
InflaRx
$1.65
+5.1%
5/28/2020 Reiterated Rating$7.00HoldView details for Ci Capital rating of InflaRx (NASDAQ:IFRX) on 5/28/2020

MarketBeat Community Rating for Ci Capital

Community Ranking:  2.6 out of 5 (
2.6 of 5 stars)
Outperform Votes:  51,834 (Vote Outperform)
Underperform Votes:  49,216 (Vote Underperform)
Total Votes:  101,050
MarketBeat's community ratings are surveys of what our community members think about Ci Capital and other research firms. Vote "Outperform" if you believe Ci Capital's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Ci Capital's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.